1. Home
  2. CRDL vs PNBK Comparison

CRDL vs PNBK Comparison

Compare CRDL & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.31

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Logo Patriot National Bancorp Inc.

PNBK

Patriot National Bancorp Inc.

HOLD

Current Price

$1.17

Market Cap

120.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDL
PNBK
Founded
2017
1999
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
132.6M
120.5M
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
CRDL
PNBK
Price
$1.31
$1.17
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
926.7K
237.8K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.31
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$0.86
52 Week High
$1.71
$2.00

Technical Indicators

Market Signals
Indicator
CRDL
PNBK
Relative Strength Index (RSI) 62.47 N/A
Support Level $0.95 N/A
Resistance Level $1.35 N/A
Average True Range (ATR) 0.10 0.00
MACD 0.01 0.00
Stochastic Oscillator 88.46 0.00

Price Performance

Historical Comparison
CRDL
PNBK

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: